STAT

SEPTEMBER 21, 2023

The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two partners formed a monopoly in order to drive up prices and boost their profits. Normally, the FTC sues the company that it believes has violated antitrust law. But this lawsuit is novel by also going after a private equity sponsor that it believes hatched the entire alleged scheme — and could serve as a warning to other private

Hospitals 363

Hospitals 363

The Pharmacist

SEPTEMBER 21, 2023

A plan to make HIV prevention drug Pre-Exposure Prophylaxis (PrEP) more widely available will be published before the end of the year, health minister Neil O’Brien has said. And he confirmed that the roadmap would explore whether the drug, which is used to reduce the chance of contracting HIV, could be made available from community […] The post Roadmap exploring PrEP access through pharmacies to be published by year end appeared first on The Pharmacist.

140

140

STAT

SEPTEMBER 21, 2023

Every day at the Kansas clinic where I perform abortions, I take care of pregnant people who have driven 10 hours or more across state lines for their procedures. They’re exhausted after moving mountains to get there: taking time off work, arranging child care, gathering funds. They’re excessively grateful, and their gratitude makes me sad.

359

359

PharmaVoice

SEPTEMBER 21, 2023

Launched this month, Brixadi from Braeburn gives patients a new tool to overcome addiction.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 21, 2023

Nine months after her mom died of ALS, Jean Swidler walked into a doctor’s office at Columbia University and asked to learn her own fate. A genetic counselor swabbed her cheek or took a blood sample — Swidler can’t remember which — and called the next month. Gently, the counselor told her she had the same mutation as her mom.

335

335

The Pharmacist

SEPTEMBER 21, 2023

The UK Government has announced funding of up to £103.5m for the development of affordable new vaccines to combat infectious diseases in developing countries. The investment – which will be made through the UK Vaccine Network – was announced along with a number of other measures by a government delegation at the UN General Assembly […] The post Government commits over £100m to global vaccine development appeared first on The Pharmacist.

Vaccines 111

Vaccines 111

Pharma Times

SEPTEMBER 21, 2023

The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes

132

132

STAT

SEPTEMBER 21, 2023

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice. Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision.

Diabetes 301

Diabetes 301

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. To establish it, the Novo Nordisk Foundation is committing up to £127 million. CEO of the Novo Nordisk Foundation Cellerator, Thomas HR Carlsen, told EPR that for cell therapy manufacturing, “The biggest challenge is producing high-quality, consistent cell therapies at the scale required for use in clinical trials… biological complexity [of living cells] means that the man

Hospitals 109

Hospitals 109

STAT

SEPTEMBER 21, 2023

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed. In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease.

Drug Development 277

Drug Development 277

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

SEPTEMBER 21, 2023

The investment will support research into cancer treatments and diagnosis - News - PharmaTimes

132

132

STAT

SEPTEMBER 21, 2023

The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. The winners of the 2023 awards, announced on Thursday in New York, distinguished themselves in AI-enabled protein modeling, groundbreaking eye test technology, and in a wide-ranging career in medical science that combined innovative discoveries with attention to m

253

253

Pharmaceutical Technology

SEPTEMBER 21, 2023

The US FDA has accepted Takeda’s NDA resubmission for TAK-721 for the short-term treatment of eosinophilic esophagitis (EoE), for review.

116

116

STAT

SEPTEMBER 21, 2023

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them.

246

246

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new report published by the Center for Global Development (CGD) has highlighted the need for coordinated global action against antimicrobial resistance (AMR). Experts from organisations such as the Wellcome Trust and Africa Centres for Disease Control and Prevention contributed to the paper, urging governments, industry and international organisations to create a political agreement, or ‘Grand Bargain’, to improve innovation, access, and stewardship for antimicrobials, particularly in low- and

99

99

STAT

SEPTEMBER 21, 2023

Thermo Fisher Scientific’s  giant plant to manufacture gene therapies for drug companies  is barely a year old, but executives at the maker of scientific tools are already talking about expanding. Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories.

235

235

Express Pharma

SEPTEMBER 21, 2023

Bharat Serums and Vaccines hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of KT Rama Rao, Minister for IT, E&C, Industries & commerce, MA &UD, Govt. of Telangana. The function was attended by E V Narasimha Reddy IAS, Vice Chairman and MD, TSIIC, Shakthi M Nagappan, CEO, Telangana Lifesciences, Government of Telangana and senior leaders of BSV – Sanjiv Navangul, MD & CEO.

Vaccines 99

Vaccines 99

STAT

SEPTEMBER 21, 2023

Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn , a potential treatment to slow the progression of ALS that has bitterly divided physicians and patient advocates. On Sept. 27, a panel of experts will consider the convoluted data supporting the potential approval of NurOwn, a stem-cell therapy the FDA previously refused to even consider.

228

228

World Pharma News

SEPTEMBER 21, 2023

At an Extraordinary General Meeting, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease of the share capital of Novartis AG in the amount of the share capital of Sandoz.

Biosimilars 95

Biosimilars 95

STAT

SEPTEMBER 21, 2023

You’re reading the web edition of D.C. Diagnosis.  Sign up here  to receive this newsletter in your inbox on Tuesdays and Thursdays. This could get ugly The Senate health committee is on a crash course today, as the panel considers a primary care and workforce bill that ranking member Bill Cassidy (R-La.) opposes. One sign of how messy it could get?

Drug Pricing 163

Drug Pricing Hospitals 163

Express Pharma

SEPTEMBER 21, 2023

Nitika Pharmaceuticals Specialities, excipient manufacturing company, recently inaugurated its microcrystalline cellulose (*Tabcell) manufacturing plant at Butibori, Nagpur. The company informed that this is India’s largest microcrystalline cellulose manufacturing facility. The inauguration of this manufacturing plant was attended by eminent personalities like Nitin Gadkari – Minister Road Transport and Highways India.

94

94

Pharma and Life Sciences Blog

SEPTEMBER 21, 2023

A Strategic Guide to Reducing Procurement Costs Through Collaboration annmarie@AZglo… Thu, 09/21/2023 - 23:13 CPOs are tasked with reining in procurement costs, but they can’t do it alone. Procurement leaders are increasingly looking to collaborate with critical partners to address their challenges, including dealing with complex supply chains, reducing costs while managing quality, and fostering strong partnerships.

Process Improvement 90

Process Improvement 90

PharmaTech

SEPTEMBER 21, 2023

FUJIFILM Diosynth Biotechnologies has finished its new viral vector gene therapy manufacturing facility in Darlington, United Kingdom.

98

98

The Pharmacist

SEPTEMBER 21, 2023

The proposed funding for the independent prescribing (IP) pathfinder service does not adequately consider the cost of running the service, sector representatives have told NHS England (NHSE). The pilot, which was launched last month, will test how pharmacist independent prescribing could be used in the community. A total of £12m in funding was allocated to […] The post Funding for IP pathfinder ‘unviable’ and ‘demotivating’, sector warns appeared first on The Pharmacist.

78

78

Pharmaceutical Technology

SEPTEMBER 21, 2023

Kezar and Everest Medicines have signed a deal for the development and commercialisation of zetomipzomib for lupus nephritis.

98

98

The Pharmacist

SEPTEMBER 21, 2023

Ongoing shortages of scabies treatments are posing a ‘significant threat’ to public health, the British Association of Dermatologists (BAD) has warned. Earlier this month, the Department of Health and Social Care issued a medication supply notice for permethrin 5% w/w cream, advising it was in ‘limited supply until further notice’ due to an increase in demand.

84

84

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

Competition watchdog probes claims of profiteering by US drugmaker in country where tuberculosis is biggest killer South Africa’s Competition Commission will investigate the American drugmaker Johnson & Johnson for the high price it has been charging for the tuberculosis medicine bedaquiline, as well as for extending its 20-year patent until 2027 to block cheaper generics from entering the country.

Drug Pricing 84

Drug Pricing 84

The Pharmacist

SEPTEMBER 21, 2023

Planning for a public-facing campaign to help raise awareness of the highly anticipated community pharmacy common conditions service in England is ‘underway’. The move comes as part of a wider national communication campaign which aims to increase the public’s understanding of changes to primary care services, as promised in the recent primary care recovery plan. […] The post Planning for Pharmacy First awareness campaign ‘underway’ appeared first on The Pharmacist.

Community Pharmacies 71

Community Pharmacies Communication 71

PharmaTech

SEPTEMBER 21, 2023

The AstraZeneca rare disease group hopes to use these new gene therapy programs to bolster its work on genomic medicine.

97

97

Outsourcing Pharma

SEPTEMBER 21, 2023

Built upon seven years of real-world patient journey data, Belong.Life has recently announced the launch of its software as a service (SaaS)-based conversational artificial intelligence (AI) cancer clinical trial matching platform.

76

76

Pharmaceutical Technology

SEPTEMBER 21, 2023

The collaboration will use Evaxion’s EDEN platform to bring an AI-designed gonorrhea mRNA vaccine to the market.

Vaccines 98

Vaccines 98

pharmaphorum

SEPTEMBER 21, 2023

The SPC waiver: How do we restore the intended balance between protection and innovation? Mike.

101

101

Outsourcing Pharma

SEPTEMBER 21, 2023

Therapeutic candidates and patient samples can be analyzed âin a fraction of the time it would normally takeâ thanks to newly patented single-molecule imaging technology.

73

73

Pharmaceutical Commerce

SEPTEMBER 21, 2023

Deal aims to provide diabetes treatment to patients across the continent.

Diabetes 105

Diabetes 105

pharmaphorum

SEPTEMBER 21, 2023

Smartphone app cuts racial disparity in post-birth care Phil.

111

111